Izotropic’s AI Breakthrough Positions IzoView to Redefine Breast CT Imaging Standards

Izotropic Announces Non-Brokered Private Placement & Extends Warrants

BreastCT.com Debuts as Go-To Resource for Breast CT Technology & Izotropic’s IzoView Device

Izotropic Introduces New Corporate Website & Brand Identity

Izotropic Launches Podcast Episode #1: Beyond the Mammogram: Rethinking the Future of Breast Imaging

Izotropic’s IzoView Positioned to Capitalize on Key Global Breast Imaging Market Drivers

Izotropic’s IzoView Breast CT Device Stands Distinct vs Existing Breast Imaging Technologies

Izotropic Provides Marketing Update

Izotropic Updates License Agreement Terms with University of California

Izotropic’s U.S. FDA Regulatory Pathway Greenlit, Company Provides Corporate Update

Izotropic Engages International Communications Consultant, Grants Incentive Stock Options & RSUs to Key Personnel, Amends Promissory Note with Primary Lender

Izotropic Completes Pre-Submission Meeting with FDA for Breast Cancer Screening Indication

Izotropic to Present at Investor Conference March 13th

FDA Sets Meeting Date with Izotropic

Izotropic Closes Non-Brokered Private Placement

Izotropic Announces Non-Brokered Private Placement- February 2025

Izotropic Announces Timelines and Milestones to IzoView Product Launch

Izotropic Featured in Announcement of Research and Markets’ U.S. Breast Cancer Analysis and Forecast

Izotropic Announces Team Leading Clinical Study Design and FDA Regulatory Submissions

Izotropic Files Pre-Submission with U.S. FDA for Breast Cancer Screening